Trifasciatoside I - Compound Card

Trifasciatoside I

Select a section from the left sidebar

Trifasciatoside I

Structure
Zoomed Structure
  • Family: Plantae - Dracaenaceae
  • Kingdom: Plantae
  • Class: Steroid
    • Subclass: Saponin
Canonical Smiles CC(=O)O[C@H]1[C@H](C)O[C@H]([C@@H]([C@@H]1OC(=O)C)O)O[C@H]1[C@@H](OC[C@@H]([C@@H]1O[C@@H]1OC[C@H]([C@@H]([C@H]1O)O)O)O)O[C@@H]1C[C@H](O)CC2=CC[C@@H]3[C@@H]([C@@]12C)CC[C@]1([C@H]3C[C@H]2[C@@H]1[C@H](C)[C@@]1(O2)OCC(=C)C(C1O)O[C@@H]1O[C@H](C)[C@@H]([C@@H]([C@H]1O)O)O)C
InChI InChI=1S/C53H80O24/c1-19-16-68-53(46(65)41(19)74-48-39(63)37(61)35(59)21(3)69-48)20(2)34-32(77-53)15-29-27-10-9-25-13-26(56)14-33(52(25,8)28(27)11-12-51(29,34)7)73-50-45(43(31(58)18-67-50)75-47-38(62)36(60)30(57)17-66-47)76-49-40(64)44(72-24(6)55)42(22(4)70-49)71-23(5)54/h9,20-22,26-50,56-65H,1,10-18H2,2-8H3/t20-,21+,22-,26+,27+,28-,29-,30+,31-,32-,33+,34-,35-,36-,37-,38+,39+,40+,41?,42-,43-,44-,45+,46?,47-,48-,49-,50-,51-,52-,53-/m0/s1
InChIKey XNVSARQHZGAIEU-XFANTQMVSA-N
Formula C53H80O24
HBA 24
HBD 10
MW 1101.2
Rotatable Bonds 10
TPSA 347.2
LogP -1.68
Number Rings 10
Number Aromatic Rings 0
Heavy Atom Count 77
Formal Charge 0
Fraction CSP3 0.89
Exact Mass 1100.5
Number of Lipinski Rule Violations 3
# Species Family Kingdom NCBI Taxonomy ID
1 Sansevieria trifasciata Dracaenaceae Plantae 39534

Showing of synonyms

  • Teponno RB, Tanaka C, et al. (2016). Trifasciatosides A-J, Steroidal Saponins from Sansevieria trifasciata.. Chemical & pharmaceutical bulletin,2016, 64(9), 1347-1355. [View] [PubMed]
Pubchem: 132580511

No compound-protein relationship available.

Structure

SMILES: O1CCCCC1OC(C(=C)CO2)CC23CC4C5C(CC4O3)C6C(CC5)C7C(=CC6)CCCC7OC8OCCC(OC9CCCCO9)C8OC1CCCCO1

Level: 4

Mol. Weight: 1101.2 g/mol

Structure

SMILES: O1CCCCC1OC(C(=C)CO2)CC23CC4C5C(CC4O3)C6C(CC5)C7C(=CC6)CCCC7OC(OCCC8)C8OC9CCCCO9

Level: 3

Mol. Weight: 1101.2 g/mol

Structure

SMILES: O1CCCCC1OC(C(=C)CO2)CC23CC4C5C(CC4O3)C6C(CC5)C7C(=CC6)CCCC7OC(OCC8)CC8OC9CCCCO9

Level: 3

Mol. Weight: 1101.2 g/mol

Structure

SMILES: O1CC(=C)CCC12CC3C4C(CC3O2)C5C(CC4)C6C(=CC5)CCCC6OC7OCCC(OC8CCCCO8)C7OC9CCCCO9

Level: 3

Mol. Weight: 1101.2 g/mol

Structure

SMILES: O1CCCCC1OC(C(=C)CO2)CC23CC4C5C(CC4O3)C6C(CC5)C7C(=CC6)CCCC7OC8CCCCO8

Level: 2

Mol. Weight: 1101.2 g/mol

Structure

SMILES: O1CC(=C)CCC12CC3C4C(CC3O2)C5C(CC4)C6C(=CC5)CCCC6OC(OCCC7)C7OC8CCCCO8

Level: 2

Mol. Weight: 1101.2 g/mol

Structure

SMILES: O1CC(=C)CCC12CC3C4C(CC3O2)C5C(CC4)C6C(=CC5)CCCC6OC(OCC7)CC7OC8CCCCO8

Level: 2

Mol. Weight: 1101.2 g/mol

Structure

SMILES: O1CCCCC1OC2C(COCC2)OC3CCCCO3

Level: 2

Mol. Weight: 1101.2 g/mol

Structure

SMILES: O1CCCCC1OC(C(=C)CO2)CC23CC4C5C(CC4O3)C6C(CC5)C7C(=CC6)CCCC7

Level: 1

Mol. Weight: 1101.2 g/mol

Structure

SMILES: O1CC(=C)CCC12CC3C4C(CC3O2)C5C(CC4)C6C(=CC5)CCCC6OC7CCCCO7

Level: 1

Mol. Weight: 1101.2 g/mol

Structure

SMILES: C1OCCCC1OC2CCCCO2

Level: 1

Mol. Weight: 1101.2 g/mol

Structure

SMILES: C1COCCC1OC2CCCCO2

Level: 1

Mol. Weight: 1101.2 g/mol

Structure

SMILES: O1CC(=C)CCC12CC3C4C(CC3O2)C5C(CC4)C6C(=CC5)CCCC6

Level: 0

Mol. Weight: 1101.2 g/mol

Structure

SMILES: C1CCOCC1

Level: 0

Mol. Weight: 1101.2 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-6.25
Human Oral Bioavailability 20%
Non-Bioavailable
Human Intestinal Absorption
Non-Absorbed
Madin-Darby Canine Kidney
1091715.89
Human Oral Bioavailability 50%
Non-Bioavailable
P-Glycoprotein Inhibitor
Inhibitor
P-Glycoprotein Substrate
Substrate
Skin Permeability
142675083.9

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
0.61
Plasma Protein Binding
75.87
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Inhibitor

Excretion

Clearance
2.19
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Toxic
Bee
Safe
Bioconcentration Factor
-3318295.42
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Toxic
Liver Injury I (DILI)
Toxic
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
-2.81
Liver Injury II
Safe
hERG Blockers
Toxic
Daphnia Maga
4.05
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-258948422167.4
Rat (Acute)
4.27
Rat (Chronic Oral)
556.62
Fathead Minnow
326867233.15
Respiratory Disease
Toxic
Skin Sensitisation
Safe
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Toxic
SR-p53
Safe

General Properties

Boiling Point
29124512828.38
Hydration Free Energy
-2.92
Log(D) at pH=7.4
-16175.5
Log(P)
-1.5
Log S
-2.84
Log(Vapor Pressure)
-959055343.73
Melting Point
228.67
pKa Acid
-6988135.26
pKa Basic
-56210.68
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
Adenylate cyclase type 5 P30803 ADCY5_CANLF Canis lupus familiaris 4 0.7348

Download SDF